A strategy for treatment of Epstein–Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells
Wagner, Hans-Joachim, Bollard, Catherine M, Vigouroux, Stéphane, Huls, M Helen, Anderson, Robert, Prentice, H Grant, Brenner, Malcolm K, Heslop, Helen E, Rooney, Cliona MVolume:
11
Année:
2003
Langue:
english
Pages:
11
DOI:
10.1038/sj.cgt.7700664
Fichier:
PDF, 251 KB
english, 2003